Outcomes with P2Y12 inhibitors after PCI according to CYP2C19 genotype - PACE-CME

Outcomes with PY inhibitors after PCI according to CYPC genotype

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Results with novel FXI inhibitor in AF set the stage for phase 3 trials
Results with novel FXI inhibitor in AF set the stage for phase 3 trials
AHA 2023
Results with novel FXI inhibitor in AF set the stage for phase 3 trials
- Christian Ruff, MD
Lower stroke risk with DOAC vs. aspirin in subclinical atrial fibrillation
Lower stroke risk with DOAC vs. aspirin in subclinical atrial fibrillation
AHA 2023
Lower stroke risk with DOAC vs. aspirin in subclinical atrial fibrillation
- Jeff Healey, MD
International survey of secondary prevention of CHD
International survey of secondary prevention of CHD
ESC Congress 2023
International survey of secondary prevention of CHD
- John W. McEvoy, MD, PhD
- Joris Holtrop, MD
What is the best antithrombotic treatment post-PCI?
What is the best antithrombotic treatment post-PCI?
ESC Congress 2023
What is the best antithrombotic treatment post-PCI?
- Marco Valgimigli, MD, PhD